242 related articles for article (PubMed ID: 26193886)
1. Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.
Deng HP; Chai JK; Shen CA; Zhang XB; Ma L; Sun TJ; Hu QG; Chi YF; Dong N
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26193886
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
4. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
Nakashima K; Yakabe Y
Biosci Biotechnol Biochem; 2007 Jul; 71(7):1650-6. PubMed ID: 17617726
[TBL] [Abstract][Full Text] [Related]
5. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
Sanchez AM; Csibi A; Raibon A; Cornille K; Gay S; Bernardi H; Candau R
J Cell Biochem; 2012 Feb; 113(2):695-710. PubMed ID: 22006269
[TBL] [Abstract][Full Text] [Related]
6. 1α,25(OH)2D3 downregulates gene expression levels of muscle ubiquitin ligases MAFbx and MuRF1 in human myotubes.
Hayakawa N; Fukumura J; Yasuno H; Fujimoto-Ouchi K; Kitamura H
Biomed Res; 2015; 36(2):71-80. PubMed ID: 25876656
[TBL] [Abstract][Full Text] [Related]
7. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
8. Glycine Regulates Protein Turnover by Activating Protein Kinase B/Mammalian Target of Rapamycin and by Inhibiting MuRF1 and Atrogin-1 Gene Expression in C2C12 Myoblasts.
Sun K; Wu Z; Ji Y; Wu G
J Nutr; 2016 Dec; 146(12):2461-2467. PubMed ID: 27798331
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase regulates E3 ligases in rodent heart.
Baskin KK; Taegtmeyer H
Circ Res; 2011 Oct; 109(10):1153-61. PubMed ID: 21921267
[TBL] [Abstract][Full Text] [Related]
10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
12. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
13. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 stimulates catabolism in C2C12 myotubes.
Li W; Moylan JS; Chambers MA; Smith J; Reid MB
Am J Physiol Cell Physiol; 2009 Sep; 297(3):C706-14. PubMed ID: 19625606
[TBL] [Abstract][Full Text] [Related]
15. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
[TBL] [Abstract][Full Text] [Related]
16. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase stabilizes FOXO3 in primary myotubes.
Sanchez AMJ; Candau R; Bernardi H
Biochem Biophys Res Commun; 2018 May; 499(3):493-498. PubMed ID: 29580989
[TBL] [Abstract][Full Text] [Related]
18. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
Edström E; Altun M; Hägglund M; Ulfhake B
J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMP-activated protein kinase stimulates Na+,K+-ATPase activity in skeletal muscle cells.
Benziane B; Björnholm M; Pirkmajer S; Austin RL; Kotova O; Viollet B; Zierath JR; Chibalin AV
J Biol Chem; 2012 Jul; 287(28):23451-63. PubMed ID: 22610379
[TBL] [Abstract][Full Text] [Related]
20. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
Eo H; Reed CH; Valentine RJ
Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
